ID   RB_RAT                  Reviewed;         920 AA.
AC   P33568; Q63527;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 3.
DT   02-OCT-2024, entry version 199.
DE   RecName: Full=Retinoblastoma-associated protein;
DE   AltName: Full=pRb;
DE            Short=Rb;
DE   AltName: Full=pp105;
GN   Name=Rb1; Synonyms=Rb-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-920.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7665085; DOI=10.1016/0378-1119(95)00154-x;
RA   Esumi M., Idutsu T., Kinugasa S., Ohno M., Nakabayashi H., Ikeda T.,
RA   Shikata T.;
RT   "Isolation and sequence polymorphism of a rat retinoblastoma (RB) cDNA.";
RL   Gene 161:231-235(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 806-920.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8441612; DOI=10.1093/nar/21.1.170;
RA   Roy N.K., Ballesteros A., Garte S.J.;
RT   "Cloning and sequence of the rat retinoblastoma (Rb) gene cDNA.";
RL   Nucleic Acids Res. 21:170-170(1993).
RN   [4]
RP   INTERACTION WITH RBBP9.
RX   PubMed=9697699; DOI=10.1038/1258;
RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;
RT   "A retinoblastoma-binding protein that affects cell-cycle control and
RT   confers transforming ability.";
RL   Nat. Genet. 19:371-374(1998).
RN   [5]
RP   PHOSPHORYLATION BY CDK1 AND CDK2, AND INTERACTION WITH CDK1 AND CDK2.
RX   PubMed=10542199; DOI=10.1074/jbc.274.45.31775;
RA   Choi K.S., Eom Y.W., Kang Y., Ha M.J., Rhee H., Yoon J.-W., Kim S.-J.;
RT   "Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger
RT   apoptosis through the phosphorylation of retinoblastoma protein in FaO
RT   hepatoma cells.";
RL   J. Biol. Chem. 274:31775-31783(1999).
RN   [6]
RP   INTERACTION WITH DNMT1.
RX   PubMed=10888886; DOI=10.1038/77124;
RA   Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L.,
RA   Wolffe A.P.;
RT   "DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription
RT   from E2F-responsive promoters.";
RL   Nat. Genet. 25:338-342(2000).
RN   [7]
RP   FUNCTION, INTERACTION WITH SMARCA4 AND HDAC1, PHOSPHORYLATION AT SER-787,
RP   DEPHOSPHORYLATION, AND MUTAGENESIS OF SER-772; SER-780 AND SER-787.
RX   PubMed=19081374; DOI=10.1016/j.neuron.2008.09.040;
RA   Qiu Z., Ghosh A.;
RT   "A calcium-dependent switch in a CREST-BRG1 complex regulates activity-
RT   dependent gene expression.";
RL   Neuron 60:775-787(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-363; THR-366 AND
RP   SER-799, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Tumor suppressor that is a key regulator of the G1/S
CC       transition of the cell cycle. The hypophosphorylated form binds
CC       transcription regulators of the E2F family, preventing transcription of
CC       E2F-responsive genes. Both physically blocks E2Fs transactivating
CC       domain and recruits chromatin-modifying enzymes that actively repress
CC       transcription. Cyclin and CDK-dependent phosphorylation of RB1 induces
CC       its dissociation from E2Fs, thereby activating transcription of E2F
CC       responsive genes and triggering entry into S phase. RB1 also promotes
CC       the G0-G1 transition upon phosphorylation and activation by
CC       CDK3/cyclin-C. Directly involved in heterochromatin formation by
CC       maintaining overall chromatin structure and, in particular, that of
CC       constitutive heterochromatin by stabilizing histone methylation.
CC       Recruits and targets histone methyltransferases SUV39H1, KMT5B and
CC       KMT5C, leading to epigenetic transcriptional repression. Controls
CC       histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase
CC       activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1
CC       by recruiting a histone deacetylase (HDAC) complex to the c-FOS
CC       promoter (PubMed:19081374). In resting neurons, transcription of the c-
CC       FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-
CC       RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is
CC       dephosphorylated by calcineurin, which leads to release of the
CC       repressor complex (By similarity). {ECO:0000250|UniProtKB:P06400,
CC       ECO:0000250|UniProtKB:P13405, ECO:0000269|PubMed:19081374}.
CC   -!- SUBUNIT: The hypophosphorylated form interacts with and sequesters the
CC       E2F1 transcription factor, thereby inhibiting E2F1 transcription (By
CC       similarity). Interacts with heterodimeric E2F/DP transcription factor
CC       complexes containing TFDP1 and either E2F1, E2F3, E2F4 or E2F5, or
CC       TFDP2 and E2F4. Interacts (when hyperphosphorylated and
CC       hypophosphorylated) with PKP3; the interaction inhibits RB1 interaction
CC       with and repression of the transcription factor E2F1, potentially via
CC       sequestering RB1 to the cytoplasm (By similarity). The unphosphorylated
CC       form interacts with EID1, ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and
CC       THOC1. Interacts with the N-terminal domain of TAF1. Interacts with
CC       SNW1, ATAD5, AATF, DNMT1, LIN9, LMNA, KMT5B, KMT5C, PELP1, UHRF2 and
CC       TMPO-alpha. Interacts with GRIP1 and UBR4. Interacts with ARID4A and
CC       KDM5B. Interacts with E4F1, LIMD1 and USP4. Interacts with PRMT2.
CC       Interacts (when methylated at Lys-852) with L3MBTL. Interacts with
CC       CHEK2; phosphorylates RB1 (By similarity). Interacts with SMARCA4/BRG1
CC       and HDAC1. Binds to CDK1 and CDK2. P-TEFB complex interacts with RB1;
CC       promotes phosphorylation of RB1 (By similarity). Interacts with RBBP9;
CC       the interaction disrupts RB1 binding to E2F1 (PubMed:9697699).
CC       Interacts with KAT2B/PCAF and EP300/P300 (By similarity). Interacts
CC       with PAX5 (By similarity). Interacts (phosphorylated and
CC       unphosphorylated) with BLCAP (By similarity). May interact with NDC80.
CC       {ECO:0000250|UniProtKB:P06400, ECO:0000250|UniProtKB:P13405,
CC       ECO:0000269|PubMed:10542199, ECO:0000269|PubMed:10888886,
CC       ECO:0000269|PubMed:19081374, ECO:0000269|PubMed:9697699}.
CC   -!- INTERACTION:
CC       P33568; O09139: E2f1; NbExp=2; IntAct=EBI-1162932, EBI-1211101;
CC       P33568; O88350: Rbbp9; NbExp=4; IntAct=EBI-1162932, EBI-1211014;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13405}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P13405}. Note=During keratinocyte
CC       differentiation, acetylation by KAT2B/PCAF is required for nuclear
CC       localization (By similarity). Localizes to the cytoplasm when
CC       hyperphosphorylated (By similarity). {ECO:0000250|UniProtKB:P06400,
CC       ECO:0000250|UniProtKB:P13405}.
CC   -!- PTM: Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-
CC       560 in G1, thereby releasing E2F1 which is then able to activate cell
CC       growth. Dephosphorylated at the late M phase. Phosphorylation of
CC       threonine residues in domain C promotes interaction between the C-
CC       terminal domain C and the Pocket domain, and thereby inhibits
CC       interactions with heterodimeric E2F/DP transcription factor complexes.
CC       CDK3/cyclin-C-mediated phosphorylation at Ser-799 and Ser-803 is
CC       required for G0-G1 transition (By similarity). Dephosphorylated at Ser-
CC       787 by calcineruin upon calcium stimulation. {ECO:0000250,
CC       ECO:0000269|PubMed:10542199, ECO:0000269|PubMed:19081374}.
CC   -!- PTM: N-terminus is methylated by METTL11A/NTM1. Monomethylation at Lys-
CC       802 by SMYD2 enhances phosphorylation at Ser-799 and Ser-803, and
CC       promotes cell cycle progression. Monomethylation at Lys-852 by SMYD2
CC       promotes interaction with L3MBTL1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Acetylated during keratinocyte differentiation. Acetylation at
CC       Ser-799 and Ser-803 regulates subcellular localization. Can be
CC       deacetylated by SIRT1. {ECO:0000250|UniProtKB:P06400}.
CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D25233; BAA04958.1; -; mRNA.
DR   EMBL; L07126; AAA42090.1; -; mRNA.
DR   PIR; S35544; S35544.
DR   RefSeq; NP_058741.1; NM_017045.1.
DR   AlphaFoldDB; P33568; -.
DR   SMR; P33568; -.
DR   BioGRID; 246837; 5.
DR   IntAct; P33568; 3.
DR   STRING; 10116.ENSRNOP00000021752; -.
DR   iPTMnet; P33568; -.
DR   PhosphoSitePlus; P33568; -.
DR   PaxDb; 10116-ENSRNOP00000021752; -.
DR   DNASU; 24708; -.
DR   Ensembl; ENSRNOT00000021752.6; ENSRNOP00000021752.6; ENSRNOG00000016029.6.
DR   Ensembl; ENSRNOT00055025330; ENSRNOP00055020690; ENSRNOG00055014785.
DR   Ensembl; ENSRNOT00060031883; ENSRNOP00060025908; ENSRNOG00060018531.
DR   Ensembl; ENSRNOT00065029547; ENSRNOP00065023462; ENSRNOG00065017661.
DR   GeneID; 24708; -.
DR   KEGG; rno:24708; -.
DR   UCSC; RGD:3540; rat.
DR   AGR; RGD:3540; -.
DR   CTD; 5925; -.
DR   RGD; 3540; Rb1.
DR   eggNOG; KOG1010; Eukaryota.
DR   InParanoid; P33568; -.
DR   OMA; VKDIGCI; -.
DR   OrthoDB; 519973at2759; -.
DR   PhylomeDB; P33568; -.
DR   TreeFam; TF105568; -.
DR   Reactome; R-RNO-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.
DR   Reactome; R-RNO-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-RNO-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-RNO-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.
DR   Reactome; R-RNO-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.
DR   Reactome; R-RNO-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   PRO; PR:P33568; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0061793; C:chromatin lock complex; ISO:RGD.
DR   GO; GO:0008024; C:cyclin/CDK positive transcription elongation factor complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0016605; C:PML body; ISS:UniProtKB.
DR   GO; GO:0035189; C:Rb-E2F complex; ISS:UniProtKB.
DR   GO; GO:0005819; C:spindle; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0061676; F:importin-alpha family protein binding; ISO:RGD.
DR   GO; GO:0019900; F:kinase binding; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0051219; F:phosphoprotein binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0051301; P:cell division; ISO:RGD.
DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISO:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0051276; P:chromosome organization; ISO:RGD.
DR   GO; GO:0048565; P:digestive tract development; ISO:RGD.
DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0034349; P:glial cell apoptotic process; ISO:RGD.
DR   GO; GO:0014009; P:glial cell proliferation; ISO:RGD.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.
DR   GO; GO:0031507; P:heterochromatin formation; ISO:RGD.
DR   GO; GO:0034088; P:maintenance of mitotic sister chromatid cohesion; ISO:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; ISS:UniProtKB.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:ARUK-UCL.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:ARUK-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISO:RGD.
DR   GO; GO:1903944; P:negative regulation of hepatocyte apoptotic process; IMP:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:1904761; P:negative regulation of myofibroblast differentiation; ISO:RGD.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:ARUK-UCL.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:1902948; P:negative regulation of tau-protein kinase activity; IMP:ARUK-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:1904028; P:positive regulation of collagen fibril organization; ISO:RGD.
DR   GO; GO:1903055; P:positive regulation of extracellular matrix organization; ISO:RGD.
DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; ISO:RGD.
DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; ISO:RGD.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0001558; P:regulation of cell growth; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISS:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0031134; P:sister chromatid biorientation; ISO:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   GO; GO:0051146; P:striated muscle cell differentiation; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd20599; CYCLIN_RB; 1.
DR   Gene3D; 1.10.472.140; -; 1.
DR   Gene3D; 6.10.140.1380; -; 1.
DR   Gene3D; 6.10.250.530; -; 1.
DR   Gene3D; 1.10.472.10; Cyclin-like; 2.
DR   InterPro; IPR013763; Cyclin-like_dom.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR002720; RB_A.
DR   InterPro; IPR002719; RB_B.
DR   InterPro; IPR015030; RB_C.
DR   InterPro; IPR028309; RB_fam.
DR   InterPro; IPR024599; RB_N.
DR   PANTHER; PTHR13742:SF17; RETINOBLASTOMA-ASSOCIATED PROTEIN; 1.
DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.
DR   Pfam; PF11934; DUF3452; 1.
DR   Pfam; PF01858; RB_A; 1.
DR   Pfam; PF01857; RB_B; 1.
DR   Pfam; PF08934; Rb_C; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SMART; SM01367; DUF3452; 1.
DR   SMART; SM01368; RB_A; 1.
DR   SMART; SM01369; Rb_C; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Cell cycle; Chromatin regulator; Cytoplasm; DNA-binding;
KW   Methylation; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Tumor suppressor.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P13405"
FT   CHAIN           2..920
FT                   /note="Retinoblastoma-associated protein"
FT                   /id="PRO_0000167838"
FT   REGION          1..34
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          340..362
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          366..763
FT                   /note="Pocket; binds T and E1A"
FT                   /evidence="ECO:0000250"
FT   REGION          366..572
FT                   /note="Domain A"
FT                   /evidence="ECO:0000250"
FT   REGION          573..631
FT                   /note="Spacer"
FT                   /evidence="ECO:0000250"
FT   REGION          632..763
FT                   /note="Domain B"
FT                   /evidence="ECO:0000250"
FT   REGION          755..920
FT                   /note="Interaction with LIMD1"
FT                   /evidence="ECO:0000250"
FT   REGION          763..920
FT                   /note="Domain C; mediates interaction with E4F1"
FT                   /evidence="ECO:0000250"
FT   REGION          895..920
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           852..868
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P13405"
FT   COMPBIAS        1..25
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        340..355
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        895..910
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N,N-dimethylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P13405"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         242
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         245
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         349
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         363
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         366
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         560
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13405"
FT   MOD_RES         604
FT                   /note="Phosphoserine; by CHEK2 and CHEK1"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         772
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400, ECO:0000255"
FT   MOD_RES         780
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400, ECO:0000255"
FT   MOD_RES         787
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19081374"
FT   MOD_RES         799
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         802
FT                   /note="N6-methyllysine; by SMYD2"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         803
FT                   /note="Phosphoserine; by CDK1 and CDK3"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         813
FT                   /note="Phosphothreonine; by CDK6"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         815
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         818
FT                   /note="Phosphothreonine; by CDK4"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         833
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         847
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         852
FT                   /note="N6-methyllysine; by SMYD2"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         865
FT                   /note="N6-acetyllysine; by PCAF"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MOD_RES         866
FT                   /note="N6-acetyllysine; by PCAF"
FT                   /evidence="ECO:0000250|UniProtKB:P06400"
FT   MUTAGEN         772
FT                   /note="S->A: Decreased association with HDAC1; when
FT                   associated with A-780 and A-787."
FT                   /evidence="ECO:0000269|PubMed:19081374"
FT   MUTAGEN         780
FT                   /note="S->A: Decreased association with HDAC1; when
FT                   associated with A-772 and A-787."
FT                   /evidence="ECO:0000269|PubMed:19081374"
FT   MUTAGEN         787
FT                   /note="S->A: Decreased association with HDAC1; when
FT                   associated with A-772 and A-780."
FT                   /evidence="ECO:0000269|PubMed:19081374"
FT   CONFLICT        668
FT                   /note="L -> P (in Ref. 2; BAA04958)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        798
FT                   /note="I -> M (in Ref. 2; BAA04958)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        866..867
FT                   /note="KL -> TW (in Ref. 3; AAA42090)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   920 AA;  105025 MW;  3BA735EA59927301 CRC64;
     MPPKAPRRTA AAEPPPPPPP PPEDDPAQDS DPEELPLIRL EFEKIEEPEF IALCQKLKVP
     DHVRERAWLT WEKVSSVDGI LEGYIQKKKE LWGICIFIAA VDLDEMPFTF TELQKSIETS
     VYKFFDLLKE IDTSTKVDNA VSRLLKKYNV LCALYSKLER TCGLIYLTQP SSGLSTEINS
     MLVLKVSWIT FLLAKGEVVQ MEDDLVISFQ LMLCVLDYFI KLSPPALLRE PYKTAATPIN
     GSPRTPRRGQ NRSARIAKQL ESDTRTIEVL CKEHECNVDE VKNVYFKNFI PFISSLGIVS
     SNGLPELESL SKRYEEVYLK SKDLDARLFL DHDKTLQTDT IDSFETERTP RKSNPDEEAN
     MVTPHTPVRT VMNTIQQLMV ILNSASDQPS ENLISYFSNC TVNPKENILK RVKDVGHIFK
     EKFASAVGQG CIDIGAQRYK LGVRLYYRVM ESMLKSEEER LSIQNFSKLL NDNIFHMSLL
     ACALEVVMAT YSRSMLQNLD SGTDLSFPWI LNVLNLKAFD FYKVIESFIK VEANLTREMI
     KHLERCEHRI MESLAWLSDS PLFDLIKQSK DGEGPDHLES ACSLSLPLQS NHTAADMYLS
     PIRSPKKRTS TTRVNSAANT ETQAASAFHT QKPLKSTSLS LFYKKVYRLA YLRLNTLCAR
     LLSDHPELEH IIWTLFQHTL ENEYELMKDR HLDQIMMCSM YGICKVKNID LKFKIIVTAY
     KDLPHAAQET FKRVLIREEE FDSIIVFYNS VFMQRLKTNI LQYASTRPPT LSPIPHIPRS
     PYKFSSSPLR IPGGNIYISP LKSPYKISEG LPTPTKMTPR SRILVSIGES FGTSEKFQKI
     NQMVCNSDRV LKRSAEGGNP PKPLKKLRFD IEGSDEADGS KHLPAESKFQ QKLAEMTSTR
     TRMQKQKLND SMEISNKEEK
//
